// App-Quantinova.ai

DXT74 : An Analysis of the Relationship between Cladribine Dose and Risk of Malignancies in Patients with Multiple Sclerosis

Researchers

Presenter

  • Stuart Cook

Principal Investigators

  • Gavin Giovannoni

  • Thomas P. Leist

  • Giancarlo Comi

  • Axel Nolting

  • Elke Sylvester

  • Dominic Jack

  • Doris Damian

  • Andrew Galazka

Medical Centers

  • Rutgers, The State University of New Jersey, New Jersey Medical School

  • Blizard Institute of Cell and Molecular Science Queen Mary University of London

  • Jefferson University Hospital,

  • Università Vita-Salute San Raffaele

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved